Trials / Completed
CompletedNCT04007341
Effect of Dexmedetomidine on the Inflammatory Response After One-lung Ventilation
Effect of Dexmedetomidine on the Inflammatory Response in Patients Undergoing Lung Resection Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Seoul St. Mary's Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The postoperative inflammatory response is significant in lung resection surgery because of major operation and one-lung ventilation. Dexmedetomidine has been shown to reduce pro-inflammatory cytokine levels and improve clinical outcomes. The aim of this study was to determine the effects of dexmedetomidine on inflammatory responses after lung resection surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | The study drug for each group was administered from the time immediately after induction of anesthesia until the end of the surgery. |
Timeline
- Start date
- 2018-07-29
- Primary completion
- 2019-01-18
- Completion
- 2019-01-18
- First posted
- 2019-07-05
- Last updated
- 2019-07-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04007341. Inclusion in this directory is not an endorsement.